ADVERTISEMENT

CME

Continuing Medical Education
Treatment of Severe, Recalcitrant, Major Aphthous Stomatitis With Adalimumab
Vujevich J, Zirwas M
Cutis. 2005;76:129-132.
We describe an 18-year-old man with a 7-year history of severe major aphthous stomatitis refractory to multiple standard therapies who responded completely to therapy with adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor α (TNF-α).

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Quick Poll
Which social media tool do you use most often to reach patients?



ADVERTISEMENT

Breaking News

More News